2011101416

14151608:00-10:0010:00-12:0012:00-13:3013:30-18:0019:00-21:0008:00-12:0012:00-13:3013:30-18:0008:00-12:00A11C22GEC101C102MRIMRIMRIMRIMRIC202C301C302C303C104+C105

2011101408:00-10:00 8:00-8:308:30-9:009:00-9:30Biomedical imaging research, Today and TomorrowHans RingertzLinkping University Hospital, Sweden20111014 10:00-10:30

10:30-11:0011:00-11:2011:20-11:40CT11:40-12:00CT20111014C303 10:00-10:20MR

10:20-10:4010:40-11:00Gd-DTPA11:00-11:2011:20-11:4011:40-12:00CT20111014 13:30-13:5013:50-14:10Recent Development of Local Ablation Therapy for Hepatic Neoplasm14:10-14:3014:30-14:50 14:50-15:00Application of Dynamic Contrast-enhanced MRI magingin Pancreatic Diseaseand Function15:00-15:10CT15:10-15:20MRIBOLDR2*CT15:20-15:3015:30-15:40CT15:40-15:503.0TMRITACE15:50-16:0016:00-16:102D

16:10-16:20CT16:20-16:3016:30-16:4016:40-16:5016:50-17:00CT1017:00-17:10CT17:10-17:20CT17:20-17:30DWI3D-FASTTOFSPGR17:30-17:40MR17:40-17:50CT17:50-18:003.0TDWIT2WI18:00-18:10MDCTMRI18:10-18:203.0T18:20-18:30CT20111015 8:00-8:20

8:20-8:408:40-9:00CT9:00-9:209:20-9:409:40-10:0010:00-10:20MRI10:20-10:30 10:30-10:40SMVSpV

10:40-10:501HMRSMR10:50-11:001H-MRS11:00-11:10LCModelHLSVD11:10-11:20CT11:20-11:30MRI11:30-11:40GSI11:40-11:50MSCT11:50-12:00-MRIAPACHEII20111015 13:30-13:50ESWAN13:50-14:10CT14:10-14:30Advances in Dual Energy imaging withComputed Tomography Christianne LeideckerSiemens Healthcare, Germany14:30-14:50MSCT14:50-15:10MR15:10-15:30MR15:30-15:5015:50-16:00 16:00-16:1064CTTN

16:10-16:201.5T16:20-16:30CT7016:30-16:40CT16:40-16:5016:50-17:00DWI17:00-17:1017:10-17:2017:20-17:3017:30-17:40ADC17:40-17:5017:50-18:00T2WIDWI18:00-18:10MDCTA20111016 8:00-8:20

8:20-8:408:40-9:009:00-9:20CT9:20-9:309:30-9:5019:50-10:10210:10-10:303C20220111014 10:00-10:3010:30-11:00 11:00-11:3011:30-11:50MR11:50-12:10CNS 13:30-13:50CT Perfusion For Ischemic StrokeYanle ZhaoKeck School of Medicine ,University of South California , USA

13:50-14:1014:10-14:30MRI14:30-14:50256CT3.0TMR14:50-15:10MRI15:10-15:20 15:20-15:303.0TMRDTI

15:30-15:4064CT15:40-15:5015:50-16:00ASL16:00-16:10CTC6CD10516:10-16:20Establishmen to fblood-brain barrier in vitro and mechanism of intevented hypoxiastate of its with human albuminan experiment Study16:20-16:30VBMMRI16:30-16:4016:40-16:50FAIR-MRI16:50-17:00MRIA20111015 8:00-8:20

8:20-8:408:40-9:00CTMRI9:00-9:209:20-9:40MSCT9:40-9:50 9:50-10:00CTMRI

10:00-10:10CTMRI10:10-10:20CT10:20-10:30HRCT10:30-10:40CT10:40-10:50CT10:50-11:00CT11:00-11:1064CTA20111015 13:30-13:50

13:50-14:1014:10-14:30CT14:30-14:50CT14:50-15:1015:10-15:3015:30-15:40 15:40-15:50

15:50-16:0016:00-16:10HRCT16:10-16:2016:20-16:3016:30-16:40CT16:40-16:50DSCT16:50-17:0064CT17:00-17:10CT:17:10-17:20CT17:20-17:30CTC20111015 8:00-8:20

8:20-8:408:40-9:00MSCT9:00-9:209:20-9:40pH9:40-10:0010:00-10:20Cerebral venous thrombosis and its complicationsChi Shing ZeeKeck School of Medicine ,University of South California , USA10:20-10:30 10:30-10:40

10:40-10:50MR10:50-11:0011:00-11:10MRA11:10-11:2011:20-11:30CTCO2CTC611:30-11:40AQP411:40-11:50C63.0T11:50-12:00MRIC20111015 13:30-13:5013:50-14:1014:10-14:3014:30-14:5014:50-15:10MR15:10-15:20 15:20-15:30CNS

15:30-15:40MRI15:40-15:5015:50-16:00MRI16:00-16:10MRI16:10-16:20SWIDTI-16:20-16:30T1-DCE-MR16:30-16:40MRI16:40-16:50MR16:50-17:0020111014 10:00-10:3010:30-11:0011:00-11:3011:30-12:00iDose4CT 13:30-13:50HRCT

13:50-14:1014:10-14:30CT-14:30-14:50PET-CT 14:50-15:0015:00-15:10CT15:10-15:20CT15:20-15:30CTH1N115:30-15:40CT15:40-15:50256iCT15:50-16:0016:00-16:10CT

16:10-16:20(ASIR)16:20-16:3085BCT16:30-16:40CT3016:40-16:50CT16:50-17:00MDCT17:00-17:1069CT17:10-17:20MSCTCOPD17:20-17:30HRCT17:30-17:40HRCT17:40-17:50CT17:50-18:003.0T balanced TEE18:00-18:10CT18:10-18:20CT20111015 8:00-8:20

8:20-8:408:40-9:00CT9:00-9:20CT 9:20-9:303.0MRI9:30-9:40HRCT9:40-9:50CTCOPD9:50-10:0010:00-10:1064SCT

10:10-10:20CT10:20-10:30CTultra-HRCTGGN10:30-10:4010:40-10:50CT10:50-11:00CT11:00-11:10CT11:10-11:20CT11:20-11:3011:30-11:40128ICT11:40-11:50HRCTCOPD11:50-12:00MSCT12:00-12:10CTCOPD20111015 13:30-13:50CT2011SCCT

13:50-14:10Advanced dose reduction technologies in Computed TomographyStefan UlzheimerSiemens Healthcare, Germany14:10-14:3014:30-14:50CTA14:50-15:1015:10-15:3015:30-15:5015:50-16:00 16:00-16:10

16:10-16:2018F-FDGPET/CT16:20-16:30NSCLCFDGN16:30-16:40CTNSE16:40-16:5016:50-17:0017:00-17:1017:10-17:2064CTA17:20-17:30AquilionONE320CT17:30-17:40CT17:40-17:50CTA17:50-18:00DSCT18:00-18:10CT20111016 8:00-8:10MRI8:10-8:20256CT8:20-8:30MSCT8:30-8:40CT8:40-8:50MRI8:50-9:00CTCT9:00-9:10MR9:10-9:20GECT9:20-9:30640CTCTA9:30-9:40CT9:40-9:503.0TMRI9:50-10:0010:00-10:10CT10:10-10:20129CT10:20-10:30ACTH13MSCT10:30-10:40640CT20111014 10:00-10:30MRI

10:30-11:00CT11:00-11:3011:30-12:00AdjacentFractureAfterPercutaneousVertebroplastyanditsPrevention20111014 13:30-14:001,2CaseDiscussion1,2

14:00-14:3014:30-15:0015:00-15:30MRI15:30-16:0016:00-16:3016:30-16:40 16:40-16:50/

16:50-17:0017:00-17:10MRIPET17:10-17:203.0TMRIbDWI17:20-17:30MR17:30-17:40ASL17:40-17:50MR17:50-18:0018:00-18:1020111015 8:00-8:301,2CaseDiscussion1,2

8:30-9:00Foot MRIRadiology Associate,LLP Corpus Christi,USA9:00-9:30MRI9:30-10:0010:00-10:3010:30-10:40 10:40-10:50VIBEMRBankart

10:50-11:00SLAP11:00-11:10MR11:10-11:20MRI11:20-11:3011:30-11:40CT11:40-11:50T211:50-12:003.0TMRI20111015 13:30-14:001,2CaseDiscussion1,2

14:00-14:3014:30-15:00---15:00-15:30qMRI15:30-16:0016:00-16:3016:30-16:40 16:40-16:50MRS

16:50-17:003DMR17:00-17:10MRIMRI17:10-17:203.0TMRI17:20-17:3031P-MRS17:30-17:4017:40-17:5031P MRS220111016 8:00-8:301,2CaseDiscussion1,2

8:30-9:009:00-9:309:30-9:40 9:40-9:50ISCDCTQCT9:50-10:00CT10:00-10:1010:10-10:20OCDMRI10:20-10:30MRI10:30-10:4064CTC10120111014 13:30-14:00

14:00-14:30 14:30-14:40Ad-TFR-Luciferase14:40-14:50RGD-GdMRI14:50-15:00MR15:00-15:10MR15:10-15:20c-erbB2SK-Br-315:20-15:3015:30-15:40BrdUMRI15:40-15:50TRAILMSCs15:50-16:0016:00-16:10Gd-nanoCPsMRI

16:10-16:20AFPSPIO16:20-16:30T16:30-16:40MR16:40-16:5016:50-17:00MRI-DCEPETAbraxane17:00-17:10BOLD17:10-17:20MRI17:20-17:30TFRVEGF17:30-17:40SPIOMSCs17:40-17:50RGD-GdC10120111015 8:00-8:30EGFR

8:30-9:00 9:00-9:10PASP-USPIOMRI9:10-9:20RNA9:20-9:309:30-9:40OxLDLUSPIOapoE-/-9:40-9:50MRI9:50-10:00--MR10:00-10:10MR10:10-10:20CD40MR10:20-10:30CTMRIC10220111014 10:00-10:30Clinical Applications of fMRI and fcMRI: Are We Ready for Prime Time?Jeffrey RobertPetrellaDuke University Medical Center,USA

10:30-11:00Principles of Functional MRI and Functional Connectivity MRIHaris Iqbal SairJohns Hopkins University, USA11:00-11:30Advanced 3D MRI Neurography in Evaluation of Sciatic Nerve and Lumbar Radicular Neuropathy Lee ChiuSaint Joseph Medical Center, USA11:30-12:00MRIC10220111014 13:30-14:00Medical Breakthrough:MR-PET ImagingLee ChiuSaint Joseph Medical Center, USA

14:00-14:30MRI14:30-15:00MRI15:00-15:30MR15:30-16:00fMRI16:00-16:10 16:10-16:20Hepatic ADC Value Correlates with Cirrhotic Severity of Patients with Biliary Atresia

16:20-16:30-R2*16:30-16:40 3.0 T MRI16:40-16:50DTI16:50-17:003.0T MR17:00-17:1017:10-17:20MRI17:20-17:30MRI17:30-17:4017:40-17:5017:50-18:0018:00-18:101.5T3.0T18:10-18:20T218:20-18:3031P-MRSMRIC10220111015 8:00-8:30Recent Advances in Neuroimaging with New Ultra High Resolution Brain PET-MRIZang Hee ChoGachon University of Medicine and ScienceKorea

8:30-9:00New Approaches for Molecular Imaging with MRIXiaoping HuEmory University and Georgia Institute of TechnologyUSA9:00-9:30MRI Gadolinium contrast use: Efficacy and SafetyOrest BoykoKeck School of Medicine , University of South California , USA9:30-10:00FMRI10:00-10:10 10:10-10:20MRIMRI10:20-10:3010:30-10:40Mn-fMRI 10:40-10:50PASL10:50-11:00Contrast-Free MRA at 3.0 T for the Detection of Intracranial Aneurysms11:00-11:1040MRI11:10-11:2011:20-11:3011:30-11:4011:40-11:5011:50-12:003.0T12:00-12:103TMR3DFLAIRMRIC10220111015 13:30-14:00

14:00-14:30USPIOMR14:30-15:0015:00-15:303.0T MR15:30-16:003.0 T MRI16:00-16:10 16:10-16:203.0 T16:20-16:30DCE-MRI16:30-16:40MRI16:40-16:50BOLD-MRI18F-FMISO PETWalker-25616:50-17:00WBDWIPET-CT17:00-17:10The predictive value of diffusion tensor imaging in the evaluation of motor function recovery in patients with cerebral infarction 17:10-17:2017:20-17:30DSCDTI17:30-17:4017:40-17:50MRI17:50-18:00MRI18:00-18:10MRI18:10-18:20MRIMRIC10220111016 8:00-8:30fMRI

8:30-9:009:00-9:30MRI9:30-10:00SWI10:00-10:3010:30-11:00MRI C20220111015 8:00-8:30

8:30-9:009:00-9:30HRCT9:30-10:0010:00-10:3010:30-11:0011:00-11:10 11:10-11:20HRCTMRI

11:20-11:30MRIADC11:30-11:403D-MRI2D-MRI, 3D-US11:40-11:50128CT11:50-12:00MRIC20220111015 13:30-14:00

14:00-14:30CT14:30-15:00MRI15:00-15:3015:30-16:0016:00-16:10 16:10-16:20MSCT16:20-16:30MSCT16:30-16:40MRI16:40-16:50320CT16:50-17:00CT Flash17:00-17:10517:10-17:20CT17:20-17:30CT17:30-17:40CT17:40-17:50MRIDTI17:50-18:00MRS18:00-18:1018:10-18:20C20220111016 8:00-8:30

8:30-9:00T2*SWAN9:00-9:30MRI9:30-10:003CDHC30120111014 10:00-10:30

10:30-11:0011:00-11:30CTA11:30-12:00C30120111014 13:30-14:00

14:00-14:30TIPS14:30-15:0015:00-15:3015:30-16:00125I 16:00-16:10 16:10-16:20Budd-Chiari16:20-16:3016:30-16:40MRITACE16:40-16:501.5T MRI16:50-17:0017:00-17:1017:10-17:2017:20-17:3017:30-17:40TCD17:40-17:5017:50-18:0018:00-18:10Solitaire AB36C30120111015 8:00-8:30TIPS

8:30-9:009:00-9:309:30-10:0010:00-10:10 10:10-10:20

10:20-10:3010:30-10:40MR10:40-10:50CTI12510:50-11:0011:00-11:1011:10-11:20TIPSSBudd-Chiari11:20-11:3011:30-11:40Meta11:40-11:5011:50-12:00+C30120111015 13:30-14:00

14:00-14:3014:30-15:00LERICHE15:00-15:30TACE15:30-16:0016:00-16:10 16:10-16:20Y-16:20-16:30-16:30-16:40A16:40-16:5016:50-17:0017:00-17:1017:10-17:20CT17:20-17:3017:30-17:4017:40-17:50CT17:50-18:00618:00-18:10C30220111014 10:00-10:30Diagnosis of Early Breast Cancer: Correlation of Conventional Imaging and MRI

10:30-11:00The Advantage of a Peer Review System in the Mammography Screening 11:10-11:20MRI11:20-11:30X11:30-11:40CADMR11:40-11:50C30220111014 13:30-14:00

14:00-14:30MRS14:30-15:0015:00-15:30X15:30-15:40 15:40-15:50XBI-RADS15:50-16:00MRIBI-RADS16:00-16:10MRX16:10-16:20XMRI16:20-16:30X16:30-16:4016:40-16:50x16:50-17:00x17:00-17:10CADXXCAD17:10-17:20X17:20-17:30C30220111015 8:00-8:30

8:30-9:009:00-9:309:30-10:00MRI10:00-10:3010:30-10:40 10:40-10:50MRI

10:50-11:00MRI11:00-11:103.0TMRI11:10-11:20MRIT111:20-11:30MRIC-erbB-2ERPR11:30-11:4011:40-11:50C30220111015 13:30-14:00MRI

14:00-14:30X14:30-14:40 14:40-14:50X14:50-15:00DBTFFDM15:00-15:10MRVX215:10******17:00C30320111014 13:30-14:00Marc Schlamann14:00-14:30To Enhance or not to Enhance: CT Contrast Agents in PET/CT Till-Alexander HeusnerDsseldorf University14:30-15:00CT:15:00-15:30Breast MRI - The Current Status Lale UmutluEssen University15:30-16:0016:00-16:307 Tesla - The More The Better ?Marc SchlamannEssen University16:30-17:00 RSNAC303201110158:00-9:00 9:00-12:00 RSNAC3032011101513:30-18:00 C104+C10520111014-16101320:30-22:30 3813592596011101321:00-23:00 38101410:30-11:30 C201115838128890101415:00-17:00 C2011101515:00-17:00 C2011101412:30-14:00 666+7771113849013723101518:00-20:00 11101412:30-14:00 33311